Board of Directors
Neville Alleyne, M.D.
Dr. Alleyne is a board-certified orthopedic surgeon and is the Director of the Orthopedic Spine Center at Tri-City Medical Center in Oceanside, CA. Dr. Alleyne’s practice is focused on treating a broad spectrum of spinal disorders, and he has established a multi-disciplinary approach, using the latest minimally invasive techniques, to relieve pain and restore spinal stability and mobility. He founded and served as chief medical director for several start-up companies developing spinal barriers and instrumentation using pedicle screws, cervical plates and artificial discs, including ProSpine, NAS Medical, and Smartdisc Inc. Dr. Alleyne is the inventor on numerous published patent applications related to spinal methods and devices. He is a member of the American Academy of Orthopedic Surgeons, the North American Spine Society, the California Orthopedic Association and the J. Robert Gladden Orthopaedic Society. Dr. Alleyne performed his fellowship training in total joint arthroplasty and spine surgery at Harvard University-Massachusetts General Hospital and New England Baptist Hospital in Boston, MA. Dr. Alleyne completed his residency training at Yale New Haven Hospital in orthopedics and general surgery in 1988. Dr. Alleyne received his medical degree from Mount Sinai School of Medicine in 1983 and was an undergraduate at Columbia University in New York, NY.
Marc Bellotti, M.S.
Mr. Bellotti is currently a partner at Fuel Source Partners, a management consulting and development execution company for the medical device industry. He has more than 35 years of medical device development experience working in both large and small companies. Prior to consulting, Marc was VP Research and Development for Sonendo, Inc. Earlier in his career, he held senior executive positions at Johnson and Johnson and Baxter Healthcare. At Johnson and Johnson, he was Worldwide VP of R&D for Advanced Sterilization Products and a member of the Board of Directors. He is a member of OCTANe and serves on the Launch Pad for new start-ups, is on the Board of Device Alliance, is an EIR at UCI Innovation Institute and is part of the Executive Next Practices Institute. Marc holds both undergraduate and graduate degrees in Biomedical Engineering from Rensselaer Polytechnic Institute and has over 100 patents and patents pending in addition to several publications.
Niv Caviar, M.B.A
Mr. Caviar is CEO of SpineOvations and is a successful life science CEO, general manager with senior functional management experience in marketing, business development, strategic planning, engineering/manufacturing and finance (Nasdaq CFO). He successfully led, raised, and negotiated 35+ partner and financial transactions for $2.5 billion in total deal capital. Mr. Caviar was responsible for commercialization/marketing and product launch for five branded products (Rx small molecule, medical device, and biologic/injectables). He is an accomplished senior leader in pharmaceutical, biotech, and medical device industry segments, with management/leadership experience in both public and private (venture and private equity) companies. Niv Caviar is the former CEO of Suneva Medical, CFO/CBO of La Jolla Pharma (LJPC: Nasdaq), VP of Bus Development and VP, Head of Dermatology Marketing at Allergan. Mr. Caviar holds an M.B.A from Harvard Business School.
Carl Kikerpill, M.S.
Carl Kikerpill spent 24 years focused on serving the Life Sciences Industry on the west coast via various client facing business development roles at Deloitte, Accenture, KPMG and PwC. He has worked with providing services to 30+ Pharma, Biotech, Med-device and diagnostic companies. He is a graduate (BS in Engineering) of the United States Military Academy at West Point and also earned a MS in Management from Troy State University. He is also a graduate of the Bio-Exec Institute at the UC Berkely Haas School of Business. In addition, he also was appointed and served for four years on a national advisory committee to the Department of Veterans Affairs.
Bill Nydam, M.B.A, C.P.A
Mr. Nydam is currently President and CEO of CryoMedix. He has over 30 years of leadership experience in healthcare. He has started several companies, turned around several companies, was the President of Endocare, a publically traded cryoablation company, and managed a venture capital fund. He has created several billions of dollars of shareholder value in his career to date. Bill received his B.S. in Accounting and Master of Business Administration at the University of California at Berkeley.
Steven Pal, M.B.A.
Steven Pal is a general partner at PDC Transaction Partners, a general life science strategy and private placement investment firm, is Chairman of the Board of Trustees for Mission Hospital in Orange County. Previously, Steven was Corporate Vice President for Allergan, Inc., where he was responsible for strategic planning and management of Allergan’s pharmaceutical and medical device businesses including Ophthalmology, Neurosciences, Dermatology, Urology as well as new technologies in Allergan’s research pipeline. Steven also spearheaded the acquisition and integration of Inamed, Inc., which brought the dermal filler Juvederm and breast implants into Allergan’s medical aesthetics portfolio. Prior to this, Steven served as Senior Vice President of Specialty Pharmaceuticals for Allergen where he led sales and marketing management for the Botox and Dermatology businesses in the U.S., including the successful launch of Botox Cosmetic as well as initial neurological Botox indications. Before joining Allergan, Steven had a successful 20-year career at Warner-Lambert Company, where he held various key U.S. and international positions. Steven graduated from McGill University in Montreal, Canada with an M.B.A. as well as a BSc in Physiology.
Stuart Young, M.D.
Dr. Young is a board certified anesthesiologist who has practiced anesthesia and pain management since 1987. Dr. Young is a member of the Anesthesia Service Medical Group (ASMG), a single specialty group of 200 physicians located in San Diego. Dr. Young has served as a member of the ASMG Board of Directors since 1996. From 1995-2001, Dr. Young served on the Board of Directors of Integrated Specialist Medical Services, a privately held anesthesia practice management company that grew to serve over 400 physicians in four states, when Team Health Corporation acquired it in 2001. Dr. Young completed his residency training at the University of Pennsylvania and the Cleveland Clinic. Dr. Young did undergraduate work at the University of Michigan and received his medical degree from Northwestern University in 1982.